Potential Drug-Drug Interaction (PDDI) Clinical Decision Support
1.0.0 - STU 1 International flag

Potential Drug-Drug Interaction (PDDI) Clinical Decision Support, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions

ValueSet: Exclude cyclosporine Medications Value Set (Experimental)

Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude Version: 1.0.0
Standards status: Informative Computable Name: Valueset_cyclosporine_exclude

Copyright/Legal: (copyright expectations unknown)

ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include these codes as defined in http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)
    CodeDisplay
    1093178Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]
    402092Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
    1093177Cyclosporine Ophthalmic Ointment [Optimmune]
    402330Cyclosporine Ophthalmic Suspension [Restasis]
    1093174Cyclosporine 0.002 MG/MG Ophthalmic Ointment
    351291Cyclosporine 0.5 MG/ML Ophthalmic Suspension
    1093173Cyclosporine Ophthalmic Ointment
    378766Cyclosporine Ophthalmic Suspension
    1156187Cyclosporine Ophthalmic Product
    1182342Optimmune Ophthalmic Product
    1182527Restasis Ophthalmic Product

 

Expansion

Expansion from tx.fhir.org based on codesystem RxNorm v03022026 (CodeSystem)

This value set contains 11 concepts

SystemCodeDisplay (en)JSONXML
http://www.nlm.nih.gov/research/umls/rxnorm  1093178cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]
http://www.nlm.nih.gov/research/umls/rxnorm  402092cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]
http://www.nlm.nih.gov/research/umls/rxnorm  1093177cyclosporine Ophthalmic Ointment [Optimmune]
http://www.nlm.nih.gov/research/umls/rxnorm  402330cyclosporine Ophthalmic Suspension [Restasis]
http://www.nlm.nih.gov/research/umls/rxnorm  1093174cyclosporine 0.002 MG/MG Ophthalmic Ointment
http://www.nlm.nih.gov/research/umls/rxnorm  351291cyclosporine 0.5 MG/ML Ophthalmic Suspension
http://www.nlm.nih.gov/research/umls/rxnorm  1093173cyclosporine Ophthalmic Ointment
http://www.nlm.nih.gov/research/umls/rxnorm  378766cyclosporine Ophthalmic Suspension
http://www.nlm.nih.gov/research/umls/rxnorm  1156187cyclosporine Ophthalmic Product
http://www.nlm.nih.gov/research/umls/rxnorm  1182342Optimmune Ophthalmic Product
http://www.nlm.nih.gov/research/umls/rxnorm  1182527Restasis Ophthalmic Product

Description of the above table(s).